BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21552146)

  • 21. Cataflam-induced esophageal ulceration.
    Isler M; Bahceci M
    Am J Gastroenterol; 2001 Apr; 96(4):1300-1. PubMed ID: 11316193
    [No Abstract]   [Full Text] [Related]  

  • 22. Reversible acute renal failure caused by the combined use of foscarnet and cyclosporin in organ transplanted patients.
    Morales JM; Muñoz MA; Fernández Zataraín G; García Cantón C; García Rubiales MA; Andrés A; Aguado JM; Gonzalez Pinto I
    Nephrol Dial Transplant; 1995; 10(6):882-3. PubMed ID: 7566623
    [No Abstract]   [Full Text] [Related]  

  • 23. Mycophenolate mofetil-related pancolitis in a kidney transplant recipient.
    Hamouda M; Mahmoudi H; Skhiri H; Elmay M
    Exp Clin Transplant; 2012 Oct; 10(5):501-5. PubMed ID: 22554227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure of cidofovir to reduce CMV-antigenemia in a child transplanted from a matched unrelated donor.
    Castagnola E; Cristina E; Dallorso S; Lanino E; Giacchino R
    J Chemother; 2001 Feb; 13(1):100-1. PubMed ID: 11233794
    [No Abstract]   [Full Text] [Related]  

  • 25. Crystal precipitation and granulomatous inflammation in multiple organs after foscarnet therapy in a lung transplant recipient.
    Tischler V; Schuurmans MM; Boehler A; Gaspert A
    J Heart Lung Transplant; 2012 Sep; 31(9):1037-40. PubMed ID: 22766024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Non-steroidal anti-inflammatory agents and digestive lesions].
    Bellanger J; Pointereau-Bellanger A
    Ann Gastroenterol Hepatol (Paris); 1989 Nov; 25(6):237-48. PubMed ID: 2694919
    [No Abstract]   [Full Text] [Related]  

  • 27. From the National Institutes of Health.
    Healy B
    JAMA; 1992 Jan; 267(2):209. PubMed ID: 1309267
    [No Abstract]   [Full Text] [Related]  

  • 28. A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients.
    Mattes FM; Hainsworth EG; Geretti AM; Nebbia G; Prentice G; Potter M; Burroughs AK; Sweny P; Hassan-Walker AF; Okwuadi S; Sabin C; Amooty G; Brown VS; Grace SC; Emery VC; Griffiths PD
    J Infect Dis; 2004 Apr; 189(8):1355-61. PubMed ID: 15073671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oesophageal ulceration associated with ingestion of mefenamic acid capsules.
    Katsinelos P; Dimiropoulos S; Vasiliadis T; Fotiadis G; Xiarchos P; Eugenidis N
    Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1431-2. PubMed ID: 10654808
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients.
    Torres-Madriz G; Boucher HW
    Clin Infect Dis; 2008 Sep; 47(5):702-11. PubMed ID: 18652557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Superficial ulceration on the vulva.
    Manam SP; Lewis FM
    Cutis; 2017 Jan; 99(1):14;38. PubMed ID: 28207008
    [No Abstract]   [Full Text] [Related]  

  • 32. [Myelo-meningoradiculitis secondary to cytomegalovirus infection in a non immunocompromised patient. Treatment with foscarnet].
    Rogeaux O; Bedos JP; Wolf M; Vachon F
    Ann Med Interne (Paris); 1992; 143(3):219-20. PubMed ID: 1326248
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group.
    Parente F; Bianchi Porro G
    Am J Gastroenterol; 1998 Mar; 93(3):317-22. PubMed ID: 9517631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytomegalovirus encephalitis resistant to anti-cytomegalovirus therapy.
    Holida MD; Trigg ME; Rumelhart SL; Lee NF; Kook H; Peters C
    AIDS; 1995 May; 9(5):531-2. PubMed ID: 7639984
    [No Abstract]   [Full Text] [Related]  

  • 35. Over-the-counter naproxen sodium and esophageal injury.
    Kahn LH; Chen M; Eaton R
    Ann Intern Med; 1997 Jun; 126(12):1006. PubMed ID: 9182468
    [No Abstract]   [Full Text] [Related]  

  • 36. [Drug-induced esophagitis, esophageal ulcer, gastro-duodenal ulcer, and small intestinal ulcer].
    Matsuhashi N; Sakurai Y
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():504-8. PubMed ID: 18074591
    [No Abstract]   [Full Text] [Related]  

  • 37. Low-dose foscarnet preemptive therapy for cytomegalovirus viremia after haploidentical bone marrow transplantation.
    Wang H; Zhu L; Xue M; Liu J; Guo Z
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):519-20. PubMed ID: 19285642
    [No Abstract]   [Full Text] [Related]  

  • 38. NSAIDs-induced digestive hemorrhage and esophageal pseudotumor: a case report.
    Sacca' N; Rodino' S; De Medici A; De Siena M; Giglio A
    Endoscopy; 1995 Oct; 27(8):632. PubMed ID: 8608768
    [No Abstract]   [Full Text] [Related]  

  • 39. [72-year-old patient with tumor and gastrointestinal bleeding].
    Gerber T
    Dtsch Med Wochenschr; 2010 Jun; 135(22):1123-4. PubMed ID: 20503138
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of refractory CMV-infection following hematopoietic stem cell transplantation with the combination of foscarnet and leflunomide.
    Ehlert K; Groll AH; Kuehn J; Vormoor J
    Klin Padiatr; 2006; 218(3):180-4. PubMed ID: 16688677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.